Industries > Pharma > Global Precision Medicine Market Forecast 2018-2028

Global Precision Medicine Market Forecast 2018-2028

Companion Diagnostics, Biomarker-based Test, Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics, Pharmaceuticals & Biotechnology Companies, Diagnostic Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Diseases

PUBLISHED: 26 March 2018
PAGES: 233
PRODUCT CODE: PHA0295

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The global precision medicine market is expected to grow at an estimated CAGR of 12.08% from 2018 to 2028. The diagnostic tool companies segment is dominating the global market and accounted for $15,974.4 million in 2017 due to the increasing demand for diagnostic and genetic tests.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 233-page report you will receive 116 tables and 56 figures– all unavailable elsewhere.

The 233-page report provides clear detailed insight into the global precision medicine market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Precision Medicine Market forecasts from 2018-2028

• Along with revenue prediction for the overall market for the global precision medicine market, our investigation shows forecasts to 2028 for the market segmented by technology:
• Companion Diagnostics
• Biomarker-based Test
• Targeted Therapeutics
• Pharmacogenomics
• Molecular Diagnostics

The forecast for each market segment is further broken down by ecosystem player and therapeutic application

For each segment, the report discusses key trends, developments and participants.

• This report breaks down the precision medicine market forecast to 2028 by ecosystem players:
• Pharmaceuticals & Biotechnology Companies
• Diagnostic Companies
• Healthcare IT/Big Data Companies
• Clinical Laboratories

The forecast for each market segment is further broken down by technology, therapeutic application and geography.

For each segment, the report discusses key trends, developments and participants.

• This report also breaks down the precision medicine market forecast to 2028 by therapeutic application:
• Cancer
• Cardiovascular Diseases
• Central Nervous System
• Infectious Diseases

The forecast for each market segment is further broken down by ecosystem player, technology and geography.

For each segment, the report discusses key trends, developments and participants.

• This study provides precision medicine market forecasts to 2028 for these regional markets:
• The Americas
• Europe
• Asia-Pacific
• RoW

The forecast for each regional market is further broken down by ecosystem player and therapeutic application

For each regional market, the report discusses key trends, developments and participants.

• This report profiles selected leading companies that are the main players in the global precision medicine market:
• Abbott Laboratories
• GE Healthcare
• GlaxoSmithKline (GSK)
• Johnson & Johnson
• Pfizer
• Laboratories Corporation of America Holdings
• Danaher Corporation

Global Precision Medicine Market Forecast 2018-2028

• Our study discusses the drivers, restraints as well as the opportunities in the global precision medicine market.

• This study also analyzed the global precision medicine market with Porter’s Five Forces Analysis as well as Value Chain Analysis

• This report discusses selected market developments in the precision medicine market: partnership, collaboration, join venture, acquisitions, product launch, product development, expansions, patents, approvals.

Visiongain’s study is intended for anyone requiring commercial analyses for the global precision medicine market. You find data, trends and predictions.

Buy our report today Global Precision Medicine Market Forecast 2018-2028: Companion Diagnostics, Biomarker-based Test, Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics, Pharmaceuticals & Biotechnology Companies, Diagnostic Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Diseases.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Precision Medicine Market Forecast 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Precision Medicine Market Forecast 2018-2028


Latest Pharma news

“Global Human Microbiome Therapeutics market set to grow to $1.6bn” by 2025 says new Visiongain report

The market for microbiome therapeutics is expected to commence around mid-2020 with the launch of new products relating to dermatology and gastrointestinal disorders.

04 December 2019

READ

“Global Next-Generation Biologics market set to grow to $42bn by 2024” says new Visiongain report

Technological developments in the next-generation biologics market will be the result of clinical development of multiple platforms in the next-generation antibody, antibody fragment and ALP sectors.

04 December 2019

READ

“Global Liquid Biopsy market set to grow to $4.9bn by 2024” says new Visiongain report

The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

04 December 2019

READ

“Global nucleic acid isolation and purification market is anticipated to reach USD 8.16 Billion by 2030”, says Visiongain

Nucleic acid separation and purification is one of modern science and technology’s most complex and critical accomplishments.

29 November 2019

READ

Categories

Category